Claudine Lizardo
Family · San Bernardino, CANPI 1316482037
Payments from drug & device makers
Across 342 payments — averaging $18.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$732
- AstraZeneca$713
- Boehringer Ingelheim$643
- Abbott$468
- Merck$349
- Bayer$333
- plus $3K from 31 others
What the payments were for
- Food & beverage$6,36099%
- Education$531%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 43 | $732 |
| AstraZeneca | 36 | $713 |
| Boehringer Ingelheim | 29 | $643 |
| Abbott | 18 | $468 |
| Merck | 18 | $349 |
| Bayer | 18 | $333 |
| Amgen | 27 | $330 |
| Lilly USA, LLC | 19 | $323 |
| Novartis | 15 | $255 |
| Pfizer | 13 | $237 |
| Corcept Therapeutics | 12 | $226 |
| GSK | 10 | $196 |
| Otsuka America Pharmaceutical, Inc. | 8 | $161 |
| Lexicon Pharmaceuticals, Inc. | 7 | $151 |
| AbbVie | 7 | $134 |
| Exact Sciences | 7 | $132 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $116 |
| Ardelyx, Inc. | 3 | $101 |
| Johnson & Johnson | 6 | $89 |
| Astellas Pharma US Inc | 3 | $82 |
| Mylan Specialty L.p. | 4 | $79 |
| Arbor Pharmaceuticals, Inc. | 6 | $73 |
| Amarin Pharma, Inc. | 5 | $72 |
| Sanofi Pasteur Inc. | 3 | $65 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $59 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $52 |
| E.r. Squibb & Sons, L.L.C. | 2 | $41 |
| Scilex Pharmaceuticals Inc. | 2 | $31 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Shield Therapeutics Inc | 1 | $22 |
| Almatica Pharma LLC | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
| Eisai Inc. | 1 | $19 |
| Metacel Pharmaceuticals LLC | 1 | $18 |
| Nevro Corp. | 1 | $18 |
| Mannkind Corporation | 1 | $15 |
| Sanofi | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FREESTYLE LIBRE 3$159
- Korlym$113
How this compares
$6,413 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 78 | $105,863 |
| FarxigaDapagliflozin Propanediol | 66 | $77,140 |
| EliquisApixaban | 49 | $48,756 |
| TrulicityDulaglutide | 36 | $47,623 |
| KerendiaFinerenone | 29 | $43,301 |
| LinzessLinaclotide | 45 | $41,961 |
| EntrestoSacubitril/Valsartan | 23 | $33,392 |
| JanuviaSitagliptin Phosphate | 21 | $22,252 |
| OzempicSemaglutide | 20 | $21,385 |
| XareltoRivaroxaban | 14 | $18,465 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 18 | $10,728 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 16 | $10,042 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 20 | $6,314 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 13 | $3,733 |
| Atorvastatin Calcium | 312 | $3,521 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $643 | $105,86378 claims |
| AstraZenecaFarxiga | $713 | $77,14066 claims |
| PfizerEliquis | $237 | $48,75649 claims |
| Lilly USA, LLCTrulicity | $323 | $47,62336 claims |
| BayerKerendia | $333 | $43,30129 claims |
| AbbVieLinzess | $134 | $41,96145 claims |
| NovartisEntresto | $255 | $33,39223 claims |
| MerckJanuvia | $349 | $22,25221 claims |
| Novo NordiskOzempic | $732 | $21,38520 claims |
| Johnson & JohnsonXarelto | $89 | $18,46514 claims |
| GSKTrelegy Ellipta | $196 | $10,04216 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,634 family providers in California.
Other family in San Bernardino
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Nancy GardettoSan Diego$394K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Jenine StoneEscondido$231K
- Erin DwyerSan Diego$189K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.